PT  - JOURNAL ARTICLE
AU  - Rocha-Filho, César Ramos
AU  - Pinto, Ana Carolina Pereira Nunes
AU  - Rocha, Aline Pereira da
AU  - Milby, Keilla Martins
AU  - de Assis Reis, Felipe Sebastião
AU  - Civile, Vinicius Tassoni
AU  - Junior, Nelson Carvas
AU  - Santos, Rodolfo Rodrigo Pereira
AU  - Ramalho, Gabriel Sodré
AU  - Trevisani, Giulia Fernandes Moça
AU  - Ferla, Laura Jantsch
AU  - Puga, Maria Eduarda dos Santos
AU  - Trevisani, Virgínia Fernandes Moça
AU  - Atallah, Alvaro Nagib
TI  - PROGNOSTIC FACTORS FOR CLINICAL COURSE OF PATIENTS WITH COVID-19: PROTOCOL FOR A RAPID LIVING SYSTEMATIC REVIEW
AID  - 10.1101/2020.05.06.20087692
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.06.20087692
4099  - http://medrxiv.org/content/early/2020/05/09/2020.05.06.20087692.short
4100  - http://medrxiv.org/content/early/2020/05/09/2020.05.06.20087692.full
AB  - CONTEXT AND OBJECTIVE Determining prognostic factors in a context of health crises such as the COVID-19 scenario may provide the best possible care for patients and optimize the management and the resource utilization of the health system. Thus, we aim to systematically review the prognostic factors for different outcomes of patients with COVID-19. DESIGN AND SETTING: Protocol for a rapid living systematic review methodology following the recommendations proposed by the Cochrane Handbook. METHODS: We will include cohorts and case-control studies. We will search Medline via PubMed, Embase via Elsevier, Cochrane Library - Cochrane Central Register of Controlled Trials (CENTRAL), Portal Regional BVS-LILACS, Scopus and WebofScience to identify studies. No language restrictions will be applied. We will perform the critical appraisal of included studies with the Quality in Prognosis Studies (QUIPS) tool and the certainty of evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE).Competing Interest StatementThe authors have declared no competing interest.Clinical TrialCRD42020183437Funding StatementThis study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES)- Finance Code 001Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article